CHiP Faculty Earn R21 Grant to Identify Lupus Patients in EHRs
CHiP would like to congratulate co-Principal Investigators Drs. Abel Kho, MD, MS (CHiP), Rosalind Ramsey-Goldman, MD, MS (Solovy Arthritis Research Society Professor of Medicine at Northwestern University), and collaborators Drs. William Thompson, PhD (CHiP), and Theresa Walunas PhD (CHiP), on being awarded an NIH R21 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Systemic lupus erythematosus (SLE) is a chronic, autoimmune, multisystem disease affecting an estimated 1.5 million Americans. The NIH R21 grant focuses on addressing the need to reduce the time it takes to identify patients with SLE. When SLE is diagnosed early, treatment can begin sooner and candidates for clinical trials can be identified earlier.
The interdisciplinary team will create a series of algorithms that pinpoint patients with SLE and assess the makeup of the SLE patient population. The team will use electronic health record (EHR) data from multiple health care institutions not only to identify patients but to cluster similar sub-groups to align these SLE patients with clinical trials and targeted therapy in a timelier fashion.
Congratulations once again to Drs. Kho, Ramsey-Goldman, Thompson, and Walunas on your award!